Shiro Akinaga
Chief Executive Officer at NANO MRNA CO.,LTD.
Net worth: 90 589 $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Tetsuhito Matsuyama | M | 61 | 10 years | |
Koji Fujimoto | M | 51 | 22 years | |
Kazunori Kataoka | M | 73 | 28 years | |
Teruo Okano | M | 75 | 28 years | |
Keiko Hattori | F | - |
AccuRna, Inc.
AccuRna, Inc. BiotechnologyHealth Technology AccuRna, Inc. researches and develops nucleic acid-based drugs using drug delivery system technologies. The company was founded on December 18, 2015 and is headquartered in Tokyo, Japan. | 7 years |
Atsushi Matsumura | M | 62 | 12 years | |
Satoru Iino | M | 58 | 12 years | |
Hiromichi Kimura | M | 73 |
AccuRna, Inc.
AccuRna, Inc. BiotechnologyHealth Technology AccuRna, Inc. researches and develops nucleic acid-based drugs using drug delivery system technologies. The company was founded on December 18, 2015 and is headquartered in Tokyo, Japan. | - |
Tomohiro Anzai | M | - |
AccuRna, Inc.
AccuRna, Inc. BiotechnologyHealth Technology AccuRna, Inc. researches and develops nucleic acid-based drugs using drug delivery system technologies. The company was founded on December 18, 2015 and is headquartered in Tokyo, Japan. | - |
Mikio Kawahara | M | - |
AccuRna, Inc.
AccuRna, Inc. BiotechnologyHealth Technology AccuRna, Inc. researches and develops nucleic acid-based drugs using drug delivery system technologies. The company was founded on December 18, 2015 and is headquartered in Tokyo, Japan. | 7 years |
Yuki Hasegawa | M | 46 | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Takashi Kawai | M | - | - |
Statistics
Country | Connections | % of total |
---|---|---|
Japan | 12 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Shiro Akinaga
- Personal Network